Topical Delivery of Nanoemulsions for Skin Cancer Treatment

    November 2023 in “ Applied Materials Today
    Joana Duarte, Ankur Sharma, Esmaeel Sharifi, Fouad Damiri, Mohammed Berrada, Moonis Ali Khan, Sachin Kumar Singh, Kamal Dua, Francisco Veiga, Filipa Mascarenhas‐Melo, Patrícia C. Pires, Ana Cláudia Paiva‐Santos
    Studysummary This review discusses the potential of topical nanoemulsions to transform skin cancer treatment by improving drug delivery and minimizing side effects, highlighting their advantages like enhanced skin permeation and controlled release, despite existing challenges.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The document explores the potential of nanoemulsions (NEs) as a promising alternative for the topical treatment of skin cancer, offering advantages such as enhanced drug solubility, stability, and targeted delivery, which improve therapeutic outcomes while minimizing systemic toxicity. Various studies demonstrate that NEs can penetrate deeper into the skin, effectively delivering drugs like leflunomide, daidzein, and 5-fluorouracil, showing significant anti-melanoma activity and improved drug permeation. Despite their promise, challenges such as long-term stability, toxicity concerns, and regulatory hurdles remain. The review suggests that continued research and investment are crucial for overcoming these challenges and realizing the full potential of NEs in skin cancer treatment.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results